(492657), A. R., (4246147), M. M., (14153292), V. P. I., (1297770), R. K., (14153295), A. R., (154400), S. U., & (14153298), S. D. (2022). Unleashing the immune response to NY-ESO-1 cancer testis antigen as a potential target for cancer immunotherapy.
Chicago Style (17th ed.) Citation(492657), Afsheen Raza, Maysaloun Merhi (4246147), Varghese Philipose Inchakalody (14153292), Roopesh Krishnankutty (1297770), Allan Relecom (14153295), Shahab Uddin (154400), and Said Dermime (14153298). Unleashing the Immune Response to NY-ESO-1 Cancer Testis Antigen as a Potential Target for Cancer Immunotherapy. 2022.
MLA (9th ed.) Citation(492657), Afsheen Raza, et al. Unleashing the Immune Response to NY-ESO-1 Cancer Testis Antigen as a Potential Target for Cancer Immunotherapy. 2022.